MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Direct reprogramming of human neural stem cells by OCT4
Direct reprogramming of human neural stem cells by OCT4
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Direct reprogramming of human neural stem cells by OCT4
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Direct reprogramming of human neural stem cells by OCT4
Direct reprogramming of human neural stem cells by OCT4

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Direct reprogramming of human neural stem cells by OCT4
Direct reprogramming of human neural stem cells by OCT4
Journal Article

Direct reprogramming of human neural stem cells by OCT4

2009
Request Book From Autostore and Choose the Collection Method
Overview
Human iPS cells made simpler Earlier this year Hans Schöler's group reported that a single transcription factor, OCT4 , was sufficient to reprogram mouse adult neural stem cells to pluripotency, making them capable of producing virtually any cell type in the right conditions. This was a striking simplification of the process — OCT4 was just one of four factors used in the early (2006/7) and classic work on producing iPS (induced pluripotent stem) cells. Now Schöler and colleagues show that OCT4 alone can also generate iPS cells from human neural stem cells. Although induced pluripotent stem (iPS) cells have been generated from mouse and human somatic cells by ectopic expression of four transcription factors, the expression of one of these four, Oct4 , is sufficient to directly reprogram adult mouse neural stem cells to iPS cells. The generation of one-factor human iPS cells from human fetal neural stem cells by ectopic expression of OCT4 alone is now reported, demonstrating that OCT4 is sufficient to reprogram human neural stem cells to pluripotency. Induced pluripotent stem (iPS) cells have been generated from mouse and human somatic cells by ectopic expression of four transcription factors ( OCT4 (also called POU5F1 ), SOX2 , c-Myc and KLF4 ) 1 , 2 , 3 , 4 , 5 , 6 , 7 . We previously reported that Oct4 alone is sufficient to reprogram directly adult mouse neural stem cells to iPS cells 8 . Here we report the generation of one-factor human iPS cells from human fetal neural stem cells (one-factor (1F) human NiPS cells) by ectopic expression of OCT4 alone. One-factor human NiPS cells resemble human embryonic stem cells in global gene expression profiles, epigenetic status, as well as pluripotency in vitro and in vivo . These findings demonstrate that the transcription factor OCT4 is sufficient to reprogram human neural stem cells to pluripotency. One-factor iPS cell generation will advance the field further towards understanding reprogramming and generating patient-specific pluripotent stem cells.